March masterclasses on mild cognitive impairment
Global experts in general practice, geriatric medicine, nursing, pharmacy and more are participating in Australia’s inaugural Driving Change Mild Cognitive Impairment (MCI) masterclasses next month.
Aimed at exploring ways to optimise the practical management of MCI, GPs are invited to attend one-day masterclasses taking place in Melbourne on Monday, 16 March and Sydney on Wednesday, 18 March, or to join a live webinar broadcasting from 8.45 am to 12.50 pm on 16 March.
MCI is reported to affect up to one million Australians and GPs in Australia are recognising a need to better recognise, diagnose, support and manage patients with the condition.
The MCI masterclasses include keynote presentations from leading experts such as Professor Phillip Scheltens, Professor of Cognitive Neurology and Director of the Alzheimer Center at Amsterdam University Medical Centers, who will present on the latest breakthrough evidence for treatment of MCI.
The Masterclass will be chaired by Associate Professor Michael Woodward, who will be joined by Dementia Australia CEO Maree McCabe and many of Australia’s leading experts across research and clinical settings.
Parallel workshops will cover topics such as detection and diagnosis; practical interventions including diet and lifestyle; monitoring and follow-up; and care planning. A panel session — Workshop insights versus the ‘ideal’ dementia pathway; constructing the national principles — will aim to capture the discussions, insights and expertise of the two masterclasses, with a view to publishing a post-event academic paper.
Interested GPs are encouraged to register now by visiting https://mciawareness.com.au/register-now/.
Click here to see the agenda.
Too much UPF could speed up biological ageing
UPFs include foods such as chips, carbonated drinks, instant noodles, ice cream, chocolate,...
Top international gong for SA-based NDIS provider
South Australian NDIS provider Utopia Care has won its second major award — being...
Depressive disorders: 70% of Australians not getting adequate treatment
Minimally adequate treatment is defined as at least one month of medication in addition to four...